You are not authorized to access this page.
Search Within

Hamza Hashmi

Formats
  1. Meeting Abstract (41)
  2. Journal Article (13)
  3. Research Letter (3)
  4. Correspondence (2)
  5. Review (2)
  6. Editorial (1)
Groups
  1. Hematologic Malignancies, Division of (30)
  2. Center for Hematologic Malignancies (29)
  3. Department of Medicine (29)
  4. Bone Marrow Transplant (28)
  5. Survivorship Research (28)
  6. Myeloma (27)

More Groups

People
  1. Saad Usmani (29)
  2. Sridevi Rajeeve (29)
  3. Sham Mailankody (27)
  4. Heather Landau (25)
  5. Alexander Lesokhin (24)
  6. Carlyn Rose Tan (24)

More People

Years
  1. 2025 (10)
  2. 2024 (52)
Publications
  1. Blood (29)
  2. Clinical Lymphoma, Myeloma and Leukemia (16)
  3. Blood Cancer Journal (4)
  4. Blood Advances (2)
  5. European Journal of Haematology (2)
  6. Transplantation and Cellular Therapy (2)

More Publications

Publishers
  1. American Society of Hematology (31)
  2. Elsevier Inc. (18)
  3. Nature Publishing Group (4)
  4. John Wiley & Sons (3)
  5. American Society of Clinical Oncology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (62)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
    Correspondence

    Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Cytokine release syndrome and neurotoxicity following CD19 CAR-T in B-cell lymphoma
    Journal Article

    Shouval, R.; Strouse, C.; Kim, S.; Oloyede, T.; Ahmed, S.; Awan, F. T.; Luan, D.; Bachanova, V.; Badar, T.; Bar, M.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • T-ICAHT: Grading and prognostic impact of thrombocytopenia after CAR T-cell therapy
    Journal Article

    Rejeski, K.; Sanz, J.; Fei, T.; Nair, M. S.; Hashmi, H.; Avigdor, A.; Beyar-Katz, O.; Bücklein, V. L.; Curran, K. J.; Einarsdottir, S.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Comparison of standard-of-care idecabtagene vicleucel and ciltacabtagene autoleucel in relapsed/refractory multiple myeloma
    Journal Article

    Hansen, D. K.; Peres, L. C.; Dima, D.; Richards, A.; Shune, L.; Afrough, A.; Midha, S.; Dhakal, B.; Kocoglu, M. H.; Atrash, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Standard-of-care idecabtagene vicleucel for relapsed/refractory multiple myeloma
    Journal Article

    Sidana, S.; Ahmed, N.; Akhtar, O. S.; Brazauskas, R.; Oloyede, T.; Bye, M.; Hansen, D.; Ferreri, C.; Freeman, C. L.; Afrough, A.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Real-world outcomes of sequential BCMA-directed therapies in relapsed refractory multiple myeloma after belantamab exposure
    Journal Article

    Mewawalla, P.; Dileo, R.; Yin, Y.; Strouse, C.; Shaikh, H.; Davis, J. A.; Alkharabsheh, O.; Rashid, A.; Ahmed, N.; Abdallah, A. O.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
    Research Letter

    Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save